Vol. 8, Part II, pp . 1193-1199, 1989 . Life Sciences Printed in Great Britain
Pergamon Press
IID?I+II~iCB Qr 11PDROG8113 IIP~i TRYPTOPHAIi YE4~BOLISY IN Y~lf F. YoGiaty and D. P. Rose Departaent aß Chsdoal Pathology, Royal Infirmary, Sheßßiald S6 3DA. (Received 4 July 1969 ; in final form 21 August 1989) TRYPTOPHAN is oo~erted to aiootinio aoid iibomiolsotide ~ a series aß metabolio reaotione, the ßirat aß which involves rupture aß the indole audeus to yield fossylhynurenine sad is catalysed by tryptophsn au~gemau (EC 1 . 13 " 1 . 12) .
An inoreaae in the activity oß thin easyms is husau liver
is brought about b9 hormonal induction ßollosing treatment with cartiaol, and results in as elevated e~xorstioa aß lgnuraaiaé , awl other intermediate me~bolltsa aß the tryptophaa-nicotinic aoid ribonucleotide pathway in urine collected aßter a tryptophan load2. The esoretioa oß tryptophan metabolites ~ women is aignifioaat~y higher than by man ßollowiag as oral dose aR' aaino acid3'~, and ~roaely elevated levels occur is the urine of osatrogsn-treated subjects and wo~ea who are ûeing ooatraoeptive steroid preparations5'6.
Thsrs do not appear to have bsea
arp atndies published aß the effect d aadroge~as on tryptophan mstaboliaw . "e have a:amined thereßase, the influence that androgens sight have upon tryptophsn aetabolism is son, and, is addition, ws have observed their effect oa the urinary e~oretioa oß ttyptophan metabolites follaeiag the administration of oortisol. Yateriala and Yethoda The aubjeota for atu~ were healti~y adult melee aged 21 to 31F years . IIri~ wan collected far 24 h after the administration aß a 5 g oral done oß lrtryptophsn .
1(ynurenine (R), 3-i~dro~]q+nureaiae (Iig), and 3-hydrc~+anthraa
ilio aoid (HA) were determined by the method aß Hsele~r~, and zauthurenio 1193
AI~ROGEN3 AND TRYPTOPHAN METABOLLSM Vol. S, No.22
1194
aoid (L) and ~anraio soil (E") sooordina to the prooedare of Satoh sad Prioi.
?he wins war aot ~drollred before aaal~sir . 1(etlpltutortsrons war
sine rnb~+~~+-~= is a dosa of 24 ~ twine daims, and llesterol+oae (id-setipl5et-androstesons-l7~-01-;-oae, Baharina Ltd. ) war ahan oral],T is a does of 20 sa three Haas s d4" " control tr~ptophan load test war carried ont fini fos ahioh the rabjeot raosind 5 a L-tgptophan at 1400 h. lour dgrs Ltar oortiral X50 a6, was ad~inistered b! intram.oular injection at 0900 h. "a oral dors of trlptaphaa was aiwu 5 h later, and all nriae war oolLoted for the rob.egneat 2~ h period.
"daiairtratioa of dther asttpltatutsraw ar
lluteralama wu oaaa»med on the folloriaa d+V and a third tryptophaa load tent was perfca~ed after 14 dolt traataeat.
The sapsriasat war ooapleted
after a fmrthsr j dqr d aadroaan adsiairtratioa
io
oars7laa ont amther
tgrptophsn load tent 5 h after the injaotiaa of ?,50 ~6 oortisol .
The reraltr are prorated is Tabler i (nei~ltatutsa~ene) cad i (1(utez~
.Sea).
ANDROGENS AND TRYPTOPHAN METABOLISM
Vol . 8, No . 22
1195
TABLE 1 Effsat af IIst2~yltestostsroae oa Tryptophan Ystabolite Bzarstions ~ solsa/2yh) aad on ths $eeponss to Cartiaol Adiinistratioa Snbjeat No . 1
2
3
4
5
~cpt .
Etpt .
E
HE
L
E"
HA
Total
(s)
119
88
108
106
66
487
(b)
576
142
161
209
105
1193
(o)
142
126
118
138
101
625
(d)
221
184
180
190
109
884
(a)
41
47
134
156
29
407
(b)
734
342
238
398
126
1838
(o)
108
77
113
106
113
517
(d)
134
86
122
125
85
552
(a)
85
50
132
172
52
491
(b)
1920
284
250
731
338
3523
(a)
360
139
180
281
88
1048
(d)
912
271
302
551
410
2446
(a)
156
72
127
162
88
605
(b)
1166
437
586
514
202
2905
(a)
90
46
141
122
69
468
(d)
595
302
295
323
167
1682
(s)
662
306
226
742
159
2095
(b)
3168
549
288
875
211
5091
(a)
1430
459
245
954
231
3319
(d)
1872
45a
288
1060
163
3833
(a)
Bkoretioa of netabolitee of ter 5 g L-tryptophaa alone.
(b)
Ezaretion after oortisol injeatlon.
(a)
Ezaretion after 14 days of androgen .
(d)
Szoretion after 17 dava oP androgen and aortiaol injeatiaa.
1198
ANDROGENS AND TRYPTOPHAN METABOLISM
Vol. 8, No. 22
TABLS 2 Sffsot d lleeterolone on Tt7ptophan llstsbolite Ezoretions (~unoles/2bh) aad oua their ~eepoaee to Cortisol Aàainistratian
Snbjeot lfo .
6
7
8
9 10
B:pt .
a
~
L
L
H~
?otal
(a)
132
90
218
280
103
823
(b)
629
510
580
380
168
2263
(o)
108
56
156
204
68
592
(d)
288
235
310
315
137
1~5
(a)
430
229
140
156
198
t149
(b)
1225
610
235
250
3~
2640
(o)
4A8
225
86
103
182
1001~
(d)
1080
560
1~
152
272
219~
(a)
418
235
120
116
198
1087
(b)
1060
470
263
203
265
2261
(e)
300
154
86
114
137
791
(d)
720
311
200
195
190
1616
(a)
216
135
108
233
101
793
(o)
127
97
93
154
64
535
(a)
850
378
302
4?1r
101
2u55
(e)
1~13
248
192
292
107
1252
Bit. (a) to (d) as Table 1 . lostr of the
5
aide snbjsots aoreted a greater total aaouat ad aetabolites is
nriae after 14 dqs treatawat with asti~ltestoaterone üan thq~ did daring the ooatrol tryptophan load test. in
3
lC, Ba and Ht were affeotsd predoainant~Y, althoagh
subjeob there were inorsaees also in the rmoretions
as
L and St .
Yestex"-
olone produced as owesall rednation in the uriaary eroretioas of ssiabolitea in all of the 5 eubjeots, cad again S, ~ and Hl were affeoted to a greater degree than L cad L .
Both aethJltutoetes+one cad ltseteiwloa . oaused s fall in the
Vol . 8, No . 22
ANDROGENS AND TRYPTOPHAN METAHOLLSM
1197
elevatid ezaretian of tsyptophan astsbolites which aaraal~y followed tare 3aduotion of tryptophan aurygaaaee bY oortisol, although the esoretion levels wave still higher than those obtained for the control stadiea . Disonesiea The increased azorstioa of 1C sad other tryptaphaa aetabolites which ooamred is ~ of the 5 subjects folloeiag the adainistratioa of aetlavlteatosteroae wu uaezpeated .
Tsstoateraae oar be converted to oestrogane is vivo became it
poaseassa the O ~-j-ozo group which ie required fca~ tre aroaatisatiaa of rlng ~ is the steroid aolsanls .
The oheaioal structure of Yesterolone does not include
such a group and it is act aetsbolised to osetroganio steroids .
lIe do act lmaw
if the ooaversion of aeth~ltestoateraae to oestrogena wsa responsible for the difference in the response of tryptophaa rtsbolisa to this androgen, sa ooapsrsd to the effect of Yeataa~olone .
The reported variation is the urinary
ezorstioa of trarptophsn astabolites with the stage of the aenatrual oyole~' 9 indicates the effeoti~ensss of relatively sash changes in oestrogen levsL, and ao perhaps the aadrogemio ioflueaoe of asthyltsetoateroae was outweighed ~ the effect of oeatrogans derived lrca it . ltesterolone adainiatratioa caused s radnotion in the eaaretioa of tryptaphaa astabolites, sad both aetl~lteetoatarons and Yeaterolone diminished the elevation of aetsbolite asaretions which noraal]y follows treataent with cortisol .
Ia our view these changes are beat explained ~ as inhibitory cation
of a~lrogeaa on tryptophea oryge~naes aotivitJ such that a reduced propartien of the ammo said load eaters the trJptophaa-~niootiaio said ribomroleotide patkw~ . IPs suggest that in the case of aet~yltsetosterone, perhaps because oestrogsna derived Pros it are proaoting as increase is the asaretion of aetabolitea, this partial inhibition of t:yptophan orygensse is not apparent aiap]y Pros the deteraiaation of astabolitee after s trfptophan load .
However, it beooaea
evident Pros s stud of the levels at uri~ry aeiabolitea when there are detaraired in urine collected after oortisol as-+w+~ tratioa, sad the outputs ooa~ared
AI~ROGENS AND TRYPTOPHAN METABOLISM
1198
Vol . 8, No. 22
with those attained when the easyae is induosd ~ oartisol is the absemoe of aaàrogsa . asgardlsas of the aeohaaio by which androgens rodity the urinar9 ezoretlon of tryptophaa netabolitea is ass the results reported here han reletanoe to the nae of loading teats far the iateatigatiaa of sbnorral trJptophaa aetaboliaa. Diatarbanoea at the t~gptophaa-nicotinic acid riboauoleotide pathway hate basa described is a tarisiy at diseaaesi0 , sad. it has been anggested that a factor which is ooaoa to shy at these is a haraoae-iadnosd rise is tr:ptaphan o~"geaaae sotitity dau to as iaorwsed oortisol secretion rats is rsspamee to the noon-specific stns at illaesai.
The elteota of oeatmgena, oontraoaptite ste-
roids, adreaoocrtiaoateroids and aurasxy an tryptophaa astaboliaa hats bees repasted prstioua],~' 6' 2, sad the present rssnlts show the aeoesaity of eaoluding also patients reoeiting eadrogems fraw clinical studies at tryptaphaa aatabolisw in sisa . ao)morledgeaent The Yestesolane need in thin inreatigstion wan a gift Iron Dr . Y.ß . Briggs at sohariag CheaioaL Ltd.
Thin wori wan supported is part by the British
E.pire Cancer Caapaign tar Beaeeroh . R,aterenoss
o.
1.
a. eL7,7Id11 sad
2.
D. P. BCBE a~ ! . YoGZNi't, Clia
BBD, J. Clic. latest . ~, 1527 (1966)
so . ~, 1 (1968) .
3. a, r. rl~, a. u. n~o~ecaem, D. DoanBK, J. e. aaDEBSaK a~ a. ~. cooD, J. Clia In
D. P. ß0B8, Clin . Chia . iota ~, 221 (1967) .
5.
D. P. soBE, C]in . Soi. ~, 265 (1966) .
6.
J. lI . PRICE, lI . J. 7SOR11TQP sad L. Y. WELLER, aces. J. Clic . Iiutrit. ~0,
452 (i%7) .
a. P . B~LEi, Clin . sol,. ~, 465 (1965) " 8. a. sar~ and J. r. PRICE, J. Biol . che.. ~, 781 (1958) . 7.
Vol . 8, No. 22
ANDZOGEN3 AND TRYPTOPIiAN METABOLISM
9. _. a. naa; a. a. ars~ aaa a. Y. ~cs, a. citu.
~. r., xus~.~o ana c. ~. aouesi, ~a..no ..
1199
ra.~st. ~, 6t7 (t961) .
.na Yol. 7,
in ci~oat cb..~t~, $ . 8obot~oa
C. P. Stwrart (sa..). load~aio Pr..., lfw Tari .oa P . 63.
lmdoa (t9~),